FULH.B. Fuller Company

$49.58-18% 1Y

$49.58

$49.0952 weeks$67.21

Is the price fair?

Fair

The yardsticks disagree: cheap against its own 5-year P/E range (2nd percentile) but the cash-flow math implies demanding growth. Treat as fair, not cheap.

1 good, 1 to watch, 1 without data

What the price assumes~+13% a yearderived · Aug 29, 2026

Priced for ~13% a year FCF growth. The price already bakes in strong, sustained growth.

Vs its own P/E rangecheapest in 41 quartersderived

Cheap vs its own history: P/E 13.8 vs a 21.8 median over 41 quarters (−37% vs median).

Against the whole market›

Percentile against every name Ryufin tracks. Higher is better; the tick marks the middle of the market. Context, not one of the checks above.

P/E (valuation)better than 75% of the market

FCF yieldbehind 72% of the market

Where this answer is blind. The growth-implied estimate assumes a fixed discount rate; capital-heavy sectors look structurally rich on it.

What FUL's price assumes

H.B. Fuller Company trades at 13.8× earnings against 29.4× for the median Specialty Chemicals name, cheaper than its own group.

13.8

Trailing P/E · Specialty Chemicals median 29.4 · cheaper than the typical name in its group

Price / sales: 0.95
Price / sales · today's price, trailing year to Aug 29, 2026
Free cash flow yield: 3.0%
Free cash flow yield · Specialty Chemicals median 4.7%
Growth the price implies: +13%
Growth the price implies · The price pays for +13% free cash flow growth a year for a decade; the business has delivered −29% a year over the last three.

Details›

Price / booktoday's price, trailing year to Aug 29, 2026: 1.56
EV / salestoday's price, trailing year to Aug 29, 2026: 1.50
Basic Materials median P/E203 names: 20.7
Specialty Chemicals median P/E43 names: 29.4
Free cash flow, trailing twelve months: $100M
Market capitalisation: $3.38B
3-year revenue growth: −0.11%
3-year free cash flow growth: −29%

What the market has paid for these earnings: 41 quarters of its own multiple × $3.59 of trailing earnings per share
Method	Per share
Its own P/E history, lower quartile	$68.26
Its own P/E history, median	$78.14
Its own P/E history, upper quartile	$89.85
52-week range	$49.09 – $67.21
Today	$49.58

Multiples from SEC filings and end-of-day closes; implied growth from a reverse discounted cash flow. Group medians across the names Ryufin tracks.

Specialty Chemicals

Ranks #14 of 33 by RyuScore